Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Cancer researchers have mapped oesophageal adenocarcinoma genes in unprecedented detail, unveiling more than half as potentially targetable by drugs already in trials for other cancers. This breakthrough could lead to personalized therapies and improved treatment options for patients.
Patients treated at minority-serving hospitals have only about two-thirds the odds of receiving palliative care compared to those receiving care at typical hospitals. The study found that racial and ethnic minorities are less likely to receive end-of-life palliative care than their counterparts, regardless of race or ethnicity.
Researchers found that terminally ill cancer patients who have hope, positivity and family support can live well during advanced stages. The study identified a five-phase iterative process involving struggling, accepting, living with the illness, sharing the experience, and reconstructing life.
Cardiff University researchers have identified a specific Fzd receptor called Fzd7 as the predominant Wnt receptor responsible for stem cell function in the stomach and intestine. Deleting this receptor makes gastric cells unable to divide and grow, providing a potential new therapeutic route for gastric cancers.
The SU2C Meg Vosburg T-Cell Lymphoma Dream Team is developing CAR-based immunotherapy strategies to target cancerous T cells without harming the immune system. The team aims to find a therapy that can improve outcomes in this patient population and make treatments more available.
Researchers at George Washington University Cancer Center have engineered a nanoimmunotherapy ensemble to increase the potency of immune checkpoint inhibitors in treating cancer. The goal is to convert 'cold' tumors into 'hot' tumors, which can be more responsive to immunotherapy.
A study of over 800 patients with laryngeal cancer found a significant risk of the disease associated with persistent sore throats combined with other symptoms. The research aims to improve early detection and treatment outcomes for cancer patients.
A new study found that extending medication time for varenicline to 24 weeks combined with 24 weeks of counseling sessions improves quitting success rates and reduces relapse risk in cancer patients. For those taking the medication as directed, quit rates increased significantly.
Researchers analyzed data from 622 cancer patients and found that those with tachycardia had a higher mortality rate compared to those without it. Tachycardia was a significant predictor of overall mortality regardless of cancer type, highlighting the need for co-management of heart and cancer conditions.
Researchers at MUSC identified targeting Sirt-1 as a promising approach to controlling Graft-VS-Host Disease (GVHD) in patients undergoing bone marrow transplants. This study showed that inhibiting Sirt-1 can suppress T cells leading to GVHD without affecting tumor relapse, offering new hope for improved patient outcomes.
A new recovery pathway has been implemented to reduce hospital stays after the Whipple operation by 15 days, allowing patients with pancreatic cancer to transition more quickly to the next phase of treatment. The study found that this accelerated care did not increase complication rates and improved patient outcomes.
The debate centers on renaming ultra-low risk cancers to avoid unnecessary investigations and treatments. Experts recommend recalibrating thresholds for cancer diagnosis to categorize very low risk cancers as benign, reducing anxiety and improving patient outcomes.
A Rutgers study has identified the NSD2 gene as a key indicator of prostate cancer's likelihood to spread. The gene's targeting could lead to early detection and longer patient survival rates.
A large study of cancer patients reveals a significant proportion are undiagnosed with acute and chronic hepatitis B and C. The findings suggest that universal screening for these viruses may be warranted to prevent life-threatening complications and improve treatment outcomes.
A recent study surveyed 450 oncologists in the US, revealing that most are unaware of how to treat patients with LGBTQ+ differences but are interested in learning more. The researchers recommend establishing protocols for treating LGBTQ cancer patients and providing education and training for physicians.
A new study published in the Journal of Clinical Oncology highlights gaps in attitudes, knowledge, and practices towards LGBTQ patients among oncologists. The research identified a need for education and training on LGBTQ-related issues to improve care for this patient population.
A study of over 8.6 million cancer patients found that white males, younger patients, and those with specific types of cancer were more likely to commit suicide. The researchers aim to identify high-risk patients to tailor treatments and develop survivorship programs.
Researchers at Osaka University found that mapping residual esophageal tumors can predict long-term prognosis and direct personalized treatment plans. The study identified four tumor remnant patterns, with specific associations to disease factors such as prognosis and metastasis risk.
A new SWOG Cancer Research Network study found that cancer patients with comorbidities such as hypertension or asthma are less likely to participate in clinical trials. The study suggests that allowing patients with manageable comorbidities to join trials could increase treatment opportunities for thousands of patients.
A new AI algorithm has been developed to analyze digital images of the cervix and identify precancerous changes, outperforming human experts in accuracy. The approach has the potential to transform cervical cancer screening, especially in areas with limited resources.
Researchers discovered a gene signature associated with treatment response and survival in patients with HPV-positive head and neck cancers. The biomarker distinguishes between two subgroups within HPV-positive patients, one with similar survival rates to HPV-negative cancers.
Researchers found that cigarette smoking was associated with poor response to cisplatin-based chemotherapy in muscle-invasive bladder cancer patients. Current smokers were also at a higher risk of cancer recurrence compared to former and never smokers, according to the study published in BJU International.
The BRCA Exchange aggregates data on thousands of inherited variants in the BRCA1 and BRCA2 genes to improve cancer prevention, screening, and intervention. The resource includes expert classifications of variants, providing information for clinicians and researchers.
Researchers have determined general population quality of life normative data for 15 individual countries, allowing for regional comparisons and valid QLQ-C30 score interpretation. National differences in quality of life scores were found, with respondents from Austria and the Netherlands reporting higher scores.
A new study published in CANCER found that suicide risk increases significantly in the first year following a cancer diagnosis, with the highest increase seen for pancreatic and lung cancers. The study's authors emphasize the importance of screening for suicide risk and providing social and emotional support to newly diagnosed patients.
A new study finds that genetic testing for breast cancer does not cause excessive anxiety, even with ambiguous results. Researchers surveyed 1,063 women and found that the type of test or result did not significantly impact worry levels.
Researchers are developing a breath test to detect cancer at an early stage by analyzing volatile organic compounds in the breath. The PAN Cancer trial aims to identify patterns of VOCs that could indicate the presence of different types of cancer.
Researchers developed two machine learning models to predict cancer patients' symptoms like depression, anxiety, and sleep disturbance. The models accurately predicted the severity of these symptoms throughout treatment, suggesting a potential improvement in quality of life for cancer patients.
A new study found that patients with stage IV ALK-positive lung cancer have a median overall survival of 6.8 years, significantly higher than the 2 percent five-year survival rate for all NSCLC patients. This optimistic outlook is attributed to targeted therapies and careful surveillance.
Medical University of South Carolina researchers found that advanced glycation end products (AGEs) can hamper response to tamoxifen therapy for ER-positive breast cancer patients. Lifestyle interventions, such as exercise and dietary counseling, may help reduce AGE levels and improve treatment outcomes.
Researchers from KAIST have identified novel pathways involving T immune cell exhaustion in liver cancer patients. The study provides evidence for designing optimal strategies for immune checkpoint blockades and offers a new path for customized medicine.
Researchers found a significant association between cancer development and an elevated risk of heart attack and stroke in the months leading up to the diagnosis. The risk was highest for patients with lung and colorectal cancers and those diagnosed with stage 3 or 4 disease, peaking in the month before diagnosis.
Researchers analyzed US population-based cancer registry data and found a significant increased risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after chemotherapy for most solid tumors. The risk was highest for certain types of cancer, such as lung, ovary, breast, and testis cancers.
A study by the University of Colorado Anschutz Medical Campus found that Facebook advertising can effectively reach rural communities with information and reminders about cancer screening. The EndCancer initiative resulted in a high engagement rate, with 96% of participants staying enrolled.
Researchers analyzed data from over 1,000 breast cancer patients and identified seven clusters of patients based on their immune evasion mechanisms. This study provides a better understanding of how breast cancer hides from the immune system, allowing oncologists to develop more personalized treatment options.
Researchers created a patient-specific tumor 'organoid' model to identify the most effective treatment for each tumor. The study successfully generated organoids for nine out of 12 patients, demonstrating the potential for personalized medicine.
A new study found that cancer patients, particularly those with blood-related cancers, have a significantly higher risk of developing shingles due to the virus reactivating later in life. New shingles vaccines offer great promise as a strategy to prevent shingles and its complications in cancer patients.
A study at Beth Israel Deaconess Medical Center found that mice infected with H. pylori bacteria and lacking claudin 18 developed precancerous cells and polyps. The loss of claudin 18 alone was enough to prompt precancerous cell development, indicating a new strategy to inhibit gastric cancer progression.
A recent study published in eLife found a strong relationship between copy number changes in genes and cancer patient outcomes. The researchers identified specific biomarkers that can determine a patient's prognosis, providing new hope for personalized cancer treatment.
Scientists identified that loss of two genes drives serrated colorectal cancer and found a combination treatment that has treated the cancer in mice. This discovery holds implications for patient care and may provide insights into the link between inflammatory bowel disease and colorectal cancer.
Researchers at McGill University Health Centre found a gene called EGFRvIII that changes the content of messages exchanged between cells, leading to aggressive brain cancer glioblastoma. This discovery holds promise for developing tests and tailored treatments for patients with glioblastoma.
A novel tool has been developed to identify genetic changes in Lynch syndrome genes associated with disease symptoms. The tool, combining laboratory test results with computer-based modeling and clinical data, achieves an accuracy of about 97 percent, making it suitable for clinical use.
A new study found that an ultrarestrictive opioid prescribing strategy was associated with fewer pills dispensed after surgery, without changes in postoperative pain scores or complications. The protocol reduced opioid pill dispensing by 72-85% for patients undergoing different types of surgery.
The study discovered fractal characteristics in gene expression, enabling the prediction of gene-to-gene interactions. This knowledge can help scientists engineer cells to perform specific tasks, such as drug delivery for cancer treatment.
Scientists at DKFZ developed XRNAX to analyze interactions between all RNA classes with cellular proteins. The new method identifies hundreds of previously unknown protein-RNA bindings and sheds light on diseases including cancer, ALS, and viral infections.
A new study identifies key molecular features that predict clinical outcomes in neuroblastoma patients. The research suggests a molecular classification scheme to select the best treatment for each patient, with tumors lacking telomere maintenance mechanisms considered low-risk and those with these features deemed higher-risk.
HIV-infected patients have a higher risk of developing cancer due to the presence of fewer T-cells in their bodies. Researchers found that exosomes play a key role in supporting cancer growth and spread in these patients, who are 500 times more likely to be diagnosed with Kaposi sarcoma.
The combination of ibrutinib plus rituximab was superior to standard treatment in improving progression-free survival and overall survival for patients with chronic lymphocytic leukemia. The treatment also showed fewer serious side effects compared to the standard FCR regimen.
New research reveals that financial difficulties are a significant strain on cancer patients, with over 20% reporting financial trouble. The study found that employment status and cancer type significantly impact financial well-being.
A Cleveland Clinic-led study found that rivaroxaban significantly reduced venous thromboembolism (VTE) and VTE-related death in outpatient, at-risk cancer patients. The medication effectively prevented blood clots during the treatment period, but risk persisted after treatment was discontinued.
Researchers developed a noninvasive diagnostic imaging method for bladder cancer using machine learning analysis of nanoresolution images from urine samples. The method achieved 94% accuracy in diagnosing bladder cancer compared to cystoscopy, the clinical standard.
A new method for detecting bladder cancer has been developed using atomic force microscopy (AFM), which can accurately identify cancerous cells in urine samples with high sensitivity. The test demonstrates over 90% sensitivity in detecting bladder cancer, compared to 20-80% for current non-invasive diagnostics.
The study found nearly 40% of large B cell lymphoma patients remained in remission beyond 2 years after receiving Yescarta treatment. Patients with refractory disease showed durable responses, giving hope for a cure.
A new study highlights the effectiveness of CAR T-cell therapy in treating diffuse large B cell lymphoma patients. The real-world outcomes show that 81% of patients responded to the therapy with 58% having no detectable cancer after four months.
Patients with a current diagnosis of lung cancer were three times more likely to die in hospital following a PCI procedure. Colon cancer had the greatest association with major bleeding complications post-PCI, with a threefold increase compared to patients with no cancer.
A new smartphone app designed for breast cancer survivors has been shown to help patients achieve significant weight loss and improvements in physical activity. The app, created at Houston Methodist, allows users to interact with their healthcare team and receive real-time feedback and guidance from a clinical dietitian.
Researchers found that it took a year or more from first spotting a symptom to beginning treatment for 10% of patients in England, Northern Ireland, and Wales. The time to diagnosis varied significantly across countries, with Denmark performing the best.
Researchers have discovered that dasatinib sensitizes triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. Additionally, a systematic review and meta-analysis found an increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy.
Researchers at Johns Hopkins Kimmel Cancer Center found that measuring circulating tumor DNA in blood samples can reveal early stages of cancer growth and spread. The study discovered new treatment options for some patients with melanoma who had mutations not detected by genetic profiling.
The Pancreatic Cancer Collective has awarded $7 million in grants to seven teams of top cancer researchers. The funding will support clinical studies and accelerate the translation of research findings into treatments, with the goal of improving patient outcomes for pancreatic cancer.